Outcomes of Kidney Recipients According to Mode of Pretransplantation Renal Replacement Therapy

S. H. Song, J. G. Lee, J. Lee, K. H. Huh, M. S. Kim, S. I. Kim, Y. S. Kim

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

The effects of pretransplantation dialysis modality on graft function are key issues in end-stage renal disease patients. The aim of this study was to evaluate post-transplantation outcomes according to pretransplantation renal replacement therapy modality in deceased-donor kidney transplantation. Among 444 deceased-donor kidney transplant recipients in Severance Hospital between April 1993 and Dec 2014, 275 who maintained a unique dialysis modality (hemodialysis [HD; n = 178] or peritoneal dialysis [PD; n = 97]) until transplantation were enrolled. There were no significant differences in sex, age, human leukocyte antigen mismatch, cold ischemic time, or duration of dialysis between groups. There was also no difference in 5-year graft survival between HD and PD groups (87.7% vs. 82.3%, respectively; P =.148). On multivariate Cox regression for risk factors affecting graft survival, renal replacement therapy modality was not found to be a risk factor. However, the rate of delayed graft function was higher in the HD group than in the PD group (32.0% vs. 19.6%, respectively; P =.028). In addition, graft function at 1 week after transplantation in the PD group was superior to that in the HD group. The pretransplantation dialysis modality was found to affect both delayed graft function and early graft function, although not graft survival.

Original languageEnglish
Pages (from-to)2461-2463
Number of pages3
JournalTransplantation Proceedings
Volume48
Issue number7
DOIs
Publication statusPublished - 2016 Sep 1

Fingerprint

Renal Replacement Therapy
Dialysis
Graft Survival
Delayed Graft Function
Kidney
Transplantation
Transplants
Tissue Donors
Cold Ischemia
Peritoneal Dialysis
HLA Antigens
Sex Characteristics
Kidney Transplantation
Chronic Kidney Failure
Renal Dialysis

All Science Journal Classification (ASJC) codes

  • Surgery
  • Transplantation

Cite this

Song, S. H. ; Lee, J. G. ; Lee, J. ; Huh, K. H. ; Kim, M. S. ; Kim, S. I. ; Kim, Y. S. / Outcomes of Kidney Recipients According to Mode of Pretransplantation Renal Replacement Therapy. In: Transplantation Proceedings. 2016 ; Vol. 48, No. 7. pp. 2461-2463.
@article{164a4804f92c478b9cf150491c833dfc,
title = "Outcomes of Kidney Recipients According to Mode of Pretransplantation Renal Replacement Therapy",
abstract = "The effects of pretransplantation dialysis modality on graft function are key issues in end-stage renal disease patients. The aim of this study was to evaluate post-transplantation outcomes according to pretransplantation renal replacement therapy modality in deceased-donor kidney transplantation. Among 444 deceased-donor kidney transplant recipients in Severance Hospital between April 1993 and Dec 2014, 275 who maintained a unique dialysis modality (hemodialysis [HD; n = 178] or peritoneal dialysis [PD; n = 97]) until transplantation were enrolled. There were no significant differences in sex, age, human leukocyte antigen mismatch, cold ischemic time, or duration of dialysis between groups. There was also no difference in 5-year graft survival between HD and PD groups (87.7{\%} vs. 82.3{\%}, respectively; P =.148). On multivariate Cox regression for risk factors affecting graft survival, renal replacement therapy modality was not found to be a risk factor. However, the rate of delayed graft function was higher in the HD group than in the PD group (32.0{\%} vs. 19.6{\%}, respectively; P =.028). In addition, graft function at 1 week after transplantation in the PD group was superior to that in the HD group. The pretransplantation dialysis modality was found to affect both delayed graft function and early graft function, although not graft survival.",
author = "Song, {S. H.} and Lee, {J. G.} and J. Lee and Huh, {K. H.} and Kim, {M. S.} and Kim, {S. I.} and Kim, {Y. S.}",
year = "2016",
month = "9",
day = "1",
doi = "10.1016/j.transproceed.2016.02.096",
language = "English",
volume = "48",
pages = "2461--2463",
journal = "Transplantation Proceedings",
issn = "0041-1345",
publisher = "Elsevier USA",
number = "7",

}

Outcomes of Kidney Recipients According to Mode of Pretransplantation Renal Replacement Therapy. / Song, S. H.; Lee, J. G.; Lee, J.; Huh, K. H.; Kim, M. S.; Kim, S. I.; Kim, Y. S.

In: Transplantation Proceedings, Vol. 48, No. 7, 01.09.2016, p. 2461-2463.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Outcomes of Kidney Recipients According to Mode of Pretransplantation Renal Replacement Therapy

AU - Song, S. H.

AU - Lee, J. G.

AU - Lee, J.

AU - Huh, K. H.

AU - Kim, M. S.

AU - Kim, S. I.

AU - Kim, Y. S.

PY - 2016/9/1

Y1 - 2016/9/1

N2 - The effects of pretransplantation dialysis modality on graft function are key issues in end-stage renal disease patients. The aim of this study was to evaluate post-transplantation outcomes according to pretransplantation renal replacement therapy modality in deceased-donor kidney transplantation. Among 444 deceased-donor kidney transplant recipients in Severance Hospital between April 1993 and Dec 2014, 275 who maintained a unique dialysis modality (hemodialysis [HD; n = 178] or peritoneal dialysis [PD; n = 97]) until transplantation were enrolled. There were no significant differences in sex, age, human leukocyte antigen mismatch, cold ischemic time, or duration of dialysis between groups. There was also no difference in 5-year graft survival between HD and PD groups (87.7% vs. 82.3%, respectively; P =.148). On multivariate Cox regression for risk factors affecting graft survival, renal replacement therapy modality was not found to be a risk factor. However, the rate of delayed graft function was higher in the HD group than in the PD group (32.0% vs. 19.6%, respectively; P =.028). In addition, graft function at 1 week after transplantation in the PD group was superior to that in the HD group. The pretransplantation dialysis modality was found to affect both delayed graft function and early graft function, although not graft survival.

AB - The effects of pretransplantation dialysis modality on graft function are key issues in end-stage renal disease patients. The aim of this study was to evaluate post-transplantation outcomes according to pretransplantation renal replacement therapy modality in deceased-donor kidney transplantation. Among 444 deceased-donor kidney transplant recipients in Severance Hospital between April 1993 and Dec 2014, 275 who maintained a unique dialysis modality (hemodialysis [HD; n = 178] or peritoneal dialysis [PD; n = 97]) until transplantation were enrolled. There were no significant differences in sex, age, human leukocyte antigen mismatch, cold ischemic time, or duration of dialysis between groups. There was also no difference in 5-year graft survival between HD and PD groups (87.7% vs. 82.3%, respectively; P =.148). On multivariate Cox regression for risk factors affecting graft survival, renal replacement therapy modality was not found to be a risk factor. However, the rate of delayed graft function was higher in the HD group than in the PD group (32.0% vs. 19.6%, respectively; P =.028). In addition, graft function at 1 week after transplantation in the PD group was superior to that in the HD group. The pretransplantation dialysis modality was found to affect both delayed graft function and early graft function, although not graft survival.

UR - http://www.scopus.com/inward/record.url?scp=84992390327&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84992390327&partnerID=8YFLogxK

U2 - 10.1016/j.transproceed.2016.02.096

DO - 10.1016/j.transproceed.2016.02.096

M3 - Article

C2 - 27742322

AN - SCOPUS:84992390327

VL - 48

SP - 2461

EP - 2463

JO - Transplantation Proceedings

JF - Transplantation Proceedings

SN - 0041-1345

IS - 7

ER -